A Randomized Clinical Trial Comparing Goserelin Acetate (ZOLADEX tm) 3.6-mg Depot and Goserelin Acetate (Zoladex) 10.8-MG Depot in Subjects with Prostate Cancer for Whom Hormonal Therapy is Indicated

Study identifier:9393IL/0028

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized Clinical Trial Comparing Goserelin Acetate (ZOLADEX tm) 3.6-mg Depot and Goserelin Acetate (Zoladex) 10.8-MG Depot in Subjects with Prostate Cancer for Whom Hormonal Therapy is Indicated

Medical condition

prostate cancer

Phase

Phase 4

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Apr 2000
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria